Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Noxafil
Active Ingredient: Posaconazole 40mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Patheon Inc, Whitby Operations, Whitby, Ontario, Canada
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 16th day of June 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).